| Authors: |
Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Tubeuf S; Institute of Health and Society (IRSS), Université Catholique de Louvain (UClouvain), Brussels, Belgium.; Institute of Economic and Social Research (IRES), Université Catholique de Louvain (UClouvain), Brussels, Belgium., Dauby N; Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.; School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium., Ethgen O; Department of Public Health, Epidemiology and Health Economics, Faculty of Medicine, University of Liège, Liège, Belgium.; SERFAN Innovation, Namur, Belgium., Marbaix S; Research Institute for Health Sciences and Technology, University of Mons-UMONS, Mons, Belgium., Willaert M; Pharma.be, Brussels, Belgium., Luyten J; Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium. |
